zyprexa

    By Melly Alazraki

    | 8:00AM 2/27/2011
    The pharmaceutical industry is ready to fall off a cliff -- a "patent cliff." Over the next few years, some of the world's most popular and lucrative medicines will go off patent, and generic competition will siphon an estimated quarter of a trillion dollars from drugmakers' bottom lines.

    By Melly Alazraki

    | 7:40AM 7/22/2010
    Eli Lilly reported its second quarter earnings per share grew a better-than-expected 11% to $1.24, handily beating expectations for earnings of $1.10 per share. Similarly, revenue jumped 9% to $5.75 billion, topping estimates of $5.58 billion.

    By Melly Alazraki

    | 6:50PM 1/27/2010
    Pharmaceutical giant Eli Lilly -- maker of Prozac and Cialis -- is expected to post solid fourth-quarter profits on Thursday after a recent restructuring. But the results will likely be lower than the year-ago quarter.

    By Melly Alazraki

    | 7:00PM 12/07/2009
    It was just at the end of October that the Journal of the American Medical Association published a study which found that children taking the latest generation of antipsychotic drugs gain significant amounts of weight -- as much as 18.7 pounds on average in just 11 weeks. Young people taking Eli...

    By David Schepp

    | 9:00AM 10/21/2009
    Shares of Apple Inc. (AAPL) were higher in trading ahead of Wall Street's opening, following a near 9-point gain on Tuesday. The Cupertino, Calif.-based computer maker reported stellar earnings earlier in the week and announced several new computer models on Tuesday, along with a new type of...